-

Alka-Seltzer® Teams Up with George Kittle to Encourage Football Fans to ‘Say Yes’ to Going Big on Game Days

Show how you #FizzAndFlex this football season for a chance to win $30,000

WHIPPANY, N.J.--(BUSINESS WIRE)--Alka-Seltzer®, the Bayer brand known for its effervescent products, is encouraging football fans to go big on gameday without the worry of getting sidelined. In partnership with tight end and good-time enthusiast, George Kittle, Alka-Seltzer is calling on fans to share how they #FizzAndFlex, whether tailgating in the blistering cold or feasting at a local establishment while cheering on their favorite team, for a chance to win prize packs and a grand prize of $30,000.

“My goal is to have a great day, every day! Whether I’m traveling for an away game, or celebrating with friends at home, Alka-Seltzer and the Alka-Seltzer Plus line-up of products help make sure unwanted symptoms don’t sneak up on me during the season and beyond,” said new Alka-Seltzer spokesperson, George Kittle.

Alka-Seltzer and George Kittle are inviting fans to share a photo or video on Instagram with the hashtags #FizzAndFlex and #Sweepstakes to show off how the brand helps them go big during game days throughout the football season. From November 6 until January 7, winners will be selected to receive an Alka-Seltzer prize pack inclusive of a $500 gift card and product samples. At the end of the sweepstakes period, one lucky winner will be randomly selected to receive the coveted $30,000 grand prize to help fund their own ultimate gameday set-up. NO PURCHASE NECESSARY TO ENTER OR WIN IN THE ALKA-SELTZER “#FIZZANDFLEX” SWEEPSTAKES. Open to legal residents of the 50 US & DC, 18 or older. Void where prohibited. Sweepstakes starts 11/6/23 and ends 1/7/2024. For Official Rules, which govern, visit bit.ly/fizzandflex Sponsor: Bayer HealthCare LLC.

The Alka-Seltzer #FizzAndFlex Sweepstakes is an extension of the brand’s Monday Morning Quarterback campaign that kicked off last year. While a “Monday Morning Quarterback” is traditionally a person who may criticize games the Monday after, Alka-Seltzer and Alka-Seltzer Plus are redefining the term in a positive manner for fans by giving them permission to “say yes” to game day without any regrets come Monday caused by unwanted symptoms – from cold and flu to hangovers and heartburn.

“With the range of symptoms that Alka-Seltzer products treat, fans can enjoy football season to the fullest and snap back quickly should any unwanted symptoms try to sideline them,” said David Ball, General Manager & Vice President, Digestive Health, Bayer Consumer Health. “Through our partnership with the ultimate hype man, George Kittle, we are cheering football fans on to say yes to their gameday celebrations knowing that Alka-Seltzer has their backs.”

For more information about Alka-Seltzer and the relief it provides, visit AlkaSeltzer.com and follow along on the brand’s Instagram.

About Alka-Seltzer®

Alka-Seltzer® and Alka-Seltzer Plus® provide amazingly fast relief for when you need to skip to the good part with a broad range of products treating everything from heartburn and cold & flu to headaches and hangovers.

For more information, please visit www.alkaseltzer.com.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. R&D expenses before special items amounted to 5.3 billion euros. For more information, go to www.bayer.com.

Contacts

Danielle K. Goonan
Senior Director, Strategic Communications, Brand PR, Social and Influencer
danielle.goonan@bayer.com

Bayer


Release Versions

Contacts

Danielle K. Goonan
Senior Director, Strategic Communications, Brand PR, Social and Influencer
danielle.goonan@bayer.com

More News From Bayer

Post Durnell Argument Scenario Statements – Attributable to Monsanto

LEVERKUSEN, Germany & ST. LOUIS--(BUSINESS WIRE)--“We appreciate the Court’s careful consideration of FIFRA’s Uniformity language and how its federal preemption provision applies to state-based label warnings. “We believe the U.S. Government and the Company made persuasive arguments that state-based warning claims ‘in addition to or different from’ warning labels approved by EPA under FIFRA, as in Durnell, are preempted, and this is necessary to avoid a patchwork of 50 different warning labels....

Media Alert for Durnell Supreme Court Argument

LEVERKUSEN, Germany & ST. LOUIS--(BUSINESS WIRE)--On April 27th, Monsanto will argue before the U.S. Supreme Court in Durnell v. Monsanto, a Roundup case involving the application of federal preemption under FIFRA. A favorable ruling by the Supreme Court would provide essential regulatory clarity for companies who seek to bring currently approved and new products to market, addressing their ability to serve U.S. farmers and consumers. Former Solicitor General Paul Clement will argue the case fo...

Bayer Announces Leadership Change Within Pharmaceuticals’ Worldwide Markets Organization in the U.S. to Support Company’s Full Growth Potential

BERLIN--(BUSINESS WIRE)--Bayer today announced a leadership change within its Pharmaceuticals’ Worldwide Markets organization to accelerate the strong performance and growth of its key pharmaceutical products in the U.S. Effective May 1, 2026, Nelson Ambrogio, currently President of Bayer’s global Radiology business, will be appointed President of Bayer U.S. Pharmaceuticals. Nelson Ambrogio will guide the U.S. Pharmaceuticals organization into its next chapter of growth and build on the strong...
Back to Newsroom